RK

Ramakrishnan Krishnan

Active Director Director DIN 02099962
DIN 02099962 First appointment Dec 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Dec 2008
Shareholding value •••• Premium profile

About Ramakrishnan Krishnan

Data last updated:

Ramakrishnan Krishnan is a Director at Lia Life Sciences Private Limited (since 2008), Managing Director at Athma Hospitals & Research Private Limited (since 2012) and Director at Trichy Premier C.T. Scans Private Limited (since 2016), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Media and Publishing. The 3 current companies with reported revenue have a combined latest revenue of ₹32.62 Cr; the largest is Lia Life Sciences Private Limited at ₹15.49 Cr (FY 2022). Earlier, Ramakrishnan Krishnan was a Director at Safion Art Private Limited (from 2009).

DIN 02099962
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2008
Oldest Company Age 38 yrs
Largest company Lia Life Sciences Private Limited · ₹15.49 Cr (FY 2022)
Combined revenue ₹32.62 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lia Life Sciences Private Limited U74900TN2008PTC070033
Director01 Dec 20082008₹15.49 Cr (FY 2022)Active
Managing Director18 Jan 20122012₹15.04 Cr (FY 2024)Active
Director22 Feb 20161988₹2.09 Cr (FY 2025)Active
Managing Director20 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Safion Art Private Limited U92140TN2009PTC073512
Director12 Nov 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lia Life Sciences Private Limited
Trichy Premier C.T. Scans Private Limited
Athma Hospitals & Research Private Limited
Safion Art Private Limited
Premium access

Shareholding and investment profile for Ramakrishnan Krishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishnan Krishnan

Ramakrishnan Krishnan currently holds 4 directorships: Lia Life Sciences Private Limited (Director, since 01 Dec 2008, revenue ₹15.49 Cr (FY 2022)); Athma Hospitals & Research Private Limited (Managing Director, since 18 Jan 2012, revenue ₹15.04 Cr (FY 2024)); Trichy Premier C.T. Scans Private Limited (Director, since 22 Feb 2016, revenue ₹2.09 Cr (FY 2025)); Paramathma Publications Private Limited (Managing Director, since 20 Dec 2022).

Ramakrishnan Krishnan was first appointed on 01 Dec 2008 as Director at Lia Life Sciences Private Limited. The most recent appointment on record is 20 Dec 2022 at Paramathma Publications Private Limited.

The 3 current companies of Ramakrishnan Krishnan that report revenue have a combined latest revenue of ₹32.62 Cr: Lia Life Sciences Private Limited ₹15.49 Cr (FY 2022); Athma Hospitals & Research Private Limited ₹15.04 Cr (FY 2024); Trichy Premier C.T. Scans Private Limited ₹2.09 Cr (FY 2025).

Ramakrishnan Krishnan held 1 earlier board appointment: Safion Art Private Limited (Director, from 12 Nov 2009).

The current boards of Ramakrishnan Krishnan's companies include Dhayanandan Sujeetha (Lia Life Sciences Private Limited), Kalaiarasan Periyasamy (Lia Life Sciences Private Limited), Karuppiah Kalaiselvi (Lia Life Sciences Private Limited), Meena (Lia Life Sciences Private Limited), Santhi Tamilarasu (Lia Life Sciences Private Limited), Sundara Rajan Srinivasan (Lia Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available